BlueNalu raises $20 million Series A funding for cell-based seafood

March 03, 2020
Last Updated:
March 03, 2020
Chemicals More...
Achieving Sustainability More...
Average importance

This Series A funding round adds some strategic investors like Nutreco and Sumitomo Corporation of Americas, among others, and will help BlueNalu construct a pilot-scale production facility in San Diego for commercial launch in late 2021. Among the cell-based seafood startups, BlueNalu has been showing quite some momentum, with its commercialization strategy and recent partnership with Nutreco. Although cell-based seafood is a fast-growing subcategory within the broader cellular agriculture space, none of the startups have managed to produce meaningful quantities of seafood so far. Given BlueNalu's ambitious timeline, its commercial success will hinge on the construction of its pilot-scale facility alongside timely regulatory approval.

For the original news article, click here .

Further Reading

Wildtype raises USD 100 million in Series B funding round to commercialize cell-based seafood

News Commentary | February 25, 2022

Led by L‑Catterton with participation from corporate investors including Cargill, this round brings Wildtype's total funding to USD 120 million. The cash infusion comes at the right time as the startup is looking to expand its production capacity of sushi‑grade, cell‑based salmon. Fish cells can be ... Not part of subscription

Umiami raised EUR 26.5 million Series A for scale-up and line expansion

News Commentary | April 08, 2022

French startup Umiami announced a EUR 26.5 million Series A round led by Astanor Ventures, Redalpine, and BPIfrance’s French Tech Seed Fund, among others. The funding will be used to further scale its protein texturization technology and bring its product to market. Umiami will first focus on ... Not part of subscription

Upside Foods raises a whopping USD 400 million in funding as it looks to commercialize cell-based meat production in the U.S.

News Commentary | April 29, 2022

Co‑led by Temasek and the Abu Dhabi Growth Fund, with participation from several strategic investors like Cargill and Givaudan, this Series C funding round is the biggest ever in the cell‑based meat space, eclipsing Future Meat’s recent financing of USD 347 million. The company will use this cash ... Not part of subscription